Annals of Hematology

, Volume 94, Issue 2, pp 359–360 | Cite as

Chronic hepatitis E virus infection following allogeneic hematopoietic stem cell transplantation: an important differential diagnosis for graft versus host disease

  • Dominik Bettinger
  • Elisabeth Schorb
  • Daniela Huzly
  • Marcus Panning
  • Annette Schmitt-Graeff
  • Philipp Kurz
  • Hartmut Bertz
  • Jürgen Finke
  • Volker Brass
  • Robert Thimme
  • Peter Hasselblatt
Letter to the Editor

References

  1. 1.
    Hoofnagle JH, Nelson KE, Purcell RH (2012) Hepatitis E. N Engl J Med 367(13):1237–1244PubMedCrossRefGoogle Scholar
  2. 2.
    Kamar N, Izopet J, Tripon S, Bismuth M, Hillaire S, Dumortier J, Radenne S, Coilly A, Garrigue V, D’Alteroche L, Buchler M, Couzi L, Lebray P, Dharancy S, Minello A, Hourmant M, Roque-Afonso AM, Abravanel F, Pol S, Rostaing L, Mallet V (2014) Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med 370(12):1111–1120PubMedCrossRefGoogle Scholar
  3. 3.
    Huzly D, Umhau M, Bettinger D, Cathomen T, Emmerich F, Hasselblatt P, Hengel H, Herzog R, Kappert O, Maassen S, Schorb E, Schulz-Huotari C, Thimme R, Unmussig R, Wenzel J, Panning M (2014) Transfusion-transmitted hepatitis E in Germany, 2013. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European Communicable Disease Bulletin 19 (21)Google Scholar
  4. 4.
    Haim-Boukobza S, Ferey MP, Vetillard AL, Jeblaoui A, Pelissier E, Pelletier G, Teillet L, Roque-Afonso AM (2012) Transfusion-transmitted hepatitis E in a misleading context of autoimmunity and drug-induced toxicity. J Hepatol 57(6):1374–1378PubMedCrossRefGoogle Scholar
  5. 5.
    Versluis J, Pas SD, Agteresch HJ, de Man RA, Maaskant J, Schipper ME, Osterhaus AD, Cornelissen JJ, van der Eijk AA (2013) Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation. Blood 122(6):1079–1086PubMedCrossRefGoogle Scholar
  6. 6.
    Abravanel F, Mansuy JM, Huynh A, Kamar N, Alric L, Peron JM, Recher C, Izopet J (2012) Low risk of hepatitis E virus reactivation after haematopoietic stem cell transplantation. J Clin Virol 54(2):152–155PubMedCrossRefGoogle Scholar
  7. 7.
    Koenecke C, Pischke S, Heim A, Raggub L, Bremer B, Raupach R, Buchholz S, Schulz T, Manns MP, Ganser A, Wedemeyer H (2012) Chronic hepatitis E in hematopoietic stem cell transplant patients in a low-endemic country? Transpl Infect Dis 14(1):103–106PubMedCrossRefGoogle Scholar
  8. 8.
    Koenecke C, Pischke S, Beutel G, Ritter U, Ganser A, Wedemeyer H, Eder M (2014) Hepatitis E virus infection in a hematopoietic stem cell donor. Bone Marrow Transplant 49(1):159–160PubMedCrossRefGoogle Scholar
  9. 9.
    Tuncer HH, Rana N, Milani C, Darko A (2012) Al-Homsi SA Gastrointestinal and hepatic complications of hematopoietic stem cell transplantation. World J Gastroenterol 18(16):1851–1860PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Dominik Bettinger
    • 1
  • Elisabeth Schorb
    • 2
  • Daniela Huzly
    • 3
  • Marcus Panning
    • 3
  • Annette Schmitt-Graeff
    • 4
  • Philipp Kurz
    • 4
  • Hartmut Bertz
    • 2
  • Jürgen Finke
    • 2
  • Volker Brass
    • 1
  • Robert Thimme
    • 1
  • Peter Hasselblatt
    • 1
  1. 1.Department of Medicine IIUniversity Hospital FreiburgFreiburgGermany
  2. 2.Department of Medicine IUniversity Hospital FreiburgFreiburgGermany
  3. 3.Institute of VirologyUniversity Hospital FreiburgFreiburgGermany
  4. 4.Institute of PathologyUniversity Hospital FreiburgFreiburgGermany

Personalised recommendations